Literature DB >> 11456214

International validation of the CLAU-S quality-of-life questionnaire for use in patients with intermittent claudication.

P Marquis1, S Comte, P Lehert.   

Abstract

BACKGROUND: Intermittent claudication (IC) occurs in patients with peripheral occlusive arterial disease and results in leg pain after walking a certain distance - the claudication distance. Until recently, no specific questionnaire has been available to measure quality of life in patients with IC.
OBJECTIVES: To validate the Claudication Scale (CLAU-S) questionnaire in patients in France, the UK, Germany and Belgium.
METHODS: Patients completed the CLAU-S questionnaire and provided demographic and clinical data. Pooled data were examined for psychometric and structural validity and test-retest reliability. Structural equation modelling (SEM) was used to confirm that the questionnaire was measuring the causal relationships involved in IC in each of the language groups studied.
RESULTS: Cross-sectional and factor analysis confirmed the validity of the questionnaire in the pooled patient population. Item convergent and discriminant coefficients and internal consistency reliability coefficients met or exceeded standard criteria. Principal component analysis confirmed the factorial structure. The underlying causal relationships in IC were identified using SEM and were consistent in all language groups studied.
CONCLUSIONS: The CLAU-S questionnaire has undergone validation in English, French, German and Flemish and has a very satisfactory validity in these languages.

Entities:  

Mesh:

Year:  2001        PMID: 11456214     DOI: 10.2165/00019053-200119060-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  21 in total

Review 1.  Quality-of-life assessment in comparative therapeutic trials and causal structure considerations in peripheral occlusive arterial disease.

Authors:  P Lehert
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Recommendations for evaluating the validity of quality of life claims for labeling and promotion.

Authors:  N K Leidy; D A Revicki; B Genesté
Journal:  Value Health       Date:  1999 Mar-Apr       Impact factor: 5.725

Review 3.  Epidemiology of peripheral arterial disease.

Authors:  B Balkau; M Vray; E Eschwege
Journal:  J Cardiovasc Pharmacol       Date:  1994       Impact factor: 3.105

4.  Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  S D Keller; J E Ware; P M Bentler; N K Aaronson; J Alonso; G Apolone; J B Bjorner; J Brazier; M Bullinger; S Kaasa; A Leplège; M Sullivan; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  Quality of life in patients with intermittent claudication.

Authors:  G Hicken; M Ameli
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-11       Impact factor: 7.069

6.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

7.  Prognostic significance of rheological and biochemical findings in patients with intermittent claudication.

Authors:  J A Dormandy; E Hoare; A H Khattab; D E Arrowsmith; T L Dormandy
Journal:  Br Med J       Date:  1973-12-08

8.  Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication.

Authors:  J Mölgaard; M R Malinow; C Lassvik; A C Holm; B Upson; A G Olsson
Journal:  J Intern Med       Date:  1992-03       Impact factor: 8.989

9.  Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience.

Authors:  W B Kannel; R B D'Agostino; P W Wilson; A J Belanger; D R Gagnon
Journal:  Am Heart J       Date:  1990-09       Impact factor: 4.749

10.  Naftidrofuryl can enhance the quality of life in patients with intermittent claudication.

Authors:  F Spengel; T M Brown; J Poth; P Lehert
Journal:  Vasa       Date:  1999-08       Impact factor: 1.961

View more
  2 in total

1.  The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study.

Authors:  Jo C Dumville; Amanda J Lee; Felicity B Smith; F Gerald R Fowkes
Journal:  Br J Gen Pract       Date:  2004-11       Impact factor: 5.386

Review 2.  Assessment of functional status and quality of life in claudication.

Authors:  Ryan J Mays; Ivan P Casserly; Wendy M Kohrt; P Michael Ho; William R Hiatt; Mark R Nehler; Judith G Regensteiner
Journal:  J Vasc Surg       Date:  2011-02-18       Impact factor: 4.268

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.